Evaluating barriers to and promotors of telehealth during the COVID-19 pandemic at U.S. cystic fibrosis programs (Commentary).

Ranganathan, Sarath C

Ranganathan, Sarath C.

Ranganathan SC; Respiratory and Sleep Medicine, Royal Children's Hospital Melbourne, Melbourne, Australia; Department of Paediatrics, University of Melbourne, Melbourne, Australia; Infection and Immunity, Murdoch Children's Research Institute, Parkville, Victoria, Australia; Lung Foundation Australia, Melbourne, Australia. Electronic address: sarath.ranganathan@rch.org.au.

J Cyst Fibros ; 20 Suppl 3: 14-15, 2021 12.

Article in English | MEDLINE | ID: covidwho-1587347

Subject(s)

COVID-19; Cystic Fibrosis; Telemedicine; Cystic Fibrosis/epidemiology; Humans; Pandemics; SARS-CoV-2

Keywords

COVID-19; Cystic fibrosis; Pandemic; Telehealth

Fulltext

XML

PubMed Links

Search on Google

Full text: Available Collection: International databases Database: MEDLINE Main subject: Telemedicine / Cystic Fibrosis / COVID-19 Type of study: Experimental Studies / Observational study Limits: Humans Language: English Journal: J Cyst Fibros Year: 2021 Document Type: Article

Similar

MEDLINE

LILACS

LIS

Fulltext

XML

PubMed Links

Search on Google